US Stocks
/
Anebulo Pharmaceuticals, Inc. Share Price

Anebulo Pharmaceuticals, Inc. Share Price

OTC: ANEB
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Anebulo Pharmaceuticals, Inc. Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Anebulo Pharmaceuticals, Inc. Share Price Chart

$0.00$0.00
L
Show Current Price
H

Anebulo Pharmaceuticals, Inc. Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
$-0.25
Revenue (TTM)
N/A
Return On Equity (TTM)
-72.78%
Profit Margin
N/A
Debt to Equity
0.04
Quarterly Earnings Growth YoY
18.82%

Anebulo Pharmaceuticals, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Sep 2024Dec 2024Mar 2025Sep 2025Dec 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$1.65M-$2.20M-$2.46M-$1.68M-$2.16M-$2.00M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A-33.09%-11.92%31.95%-28.77%7.36%

Anebulo Pharmaceuticals, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
RevenueN/AN/AN/AN/AN/A
Net Profit-$30.25M-$6.83M-$11.73M-$8.20M-$8.48M
Net Profit MarginN/AN/AN/AN/AN/A
Income ChangeN/A77.44%-71.89%30.09%-3.45%

About Anebulo Pharmaceuticals, Inc.

Anebulo Pharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing treatments for unintentional cannabis poisoning, acute cannabinoid intoxication, and acute cannabis-induced conditions in the United States. Its lead product candidate is the selonabant, a small molecule antagonist of cannabinoid binding receptor type-1, which is in a phase II clinical trial to address the unmet medical need for a specific antidote for cannabis toxicity. The company was incorporated in 2020 and is based in Lakeway, Texas.

Anebulo Pharmaceuticals, Inc. Historical Returns

MonthOpenCloseChange %

ANEB Share Price FAQs

What is Anebulo Pharmaceuticals, Inc. share price today?

chevron-up
Anebulo Pharmaceuticals, Inc. share price today is $0.00 as on September 10, 2026 at 10:06 am IST.

What is the 52 week high and 52 week low of Anebulo Pharmaceuticals, Inc. stock?

chevron-up
52 week high/low data for Anebulo Pharmaceuticals, Inc. is currently unavailable.

What is ANEB's net income for the last quarter?

chevron-up
ANEB's net income for the last quarter is -0.00B USD.

Can I buy ANEB shares in India?

chevron-up
Yes. You can buy ANEB in India by opening an international trading account.